AQR Capital Management LLC Grows Stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

AQR Capital Management LLC grew its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 119.0% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 382,195 shares of the medical instruments supplier's stock after acquiring an additional 207,704 shares during the period. AQR Capital Management LLC owned 0.18% of DENTSPLY SIRONA worth $9,520,000 at the end of the most recent reporting period.

Other institutional investors have also modified their holdings of the company. Treasurer of the State of North Carolina lifted its stake in DENTSPLY SIRONA by 1.0% in the fourth quarter. Treasurer of the State of North Carolina now owns 93,762 shares of the medical instruments supplier's stock worth $3,337,000 after acquiring an additional 920 shares during the period. Bank of Nova Scotia increased its holdings in DENTSPLY SIRONA by 92.3% during the fourth quarter. Bank of Nova Scotia now owns 16,141 shares of the medical instruments supplier's stock valued at $574,000 after buying an additional 7,747 shares during the period. KBC Group NV increased its holdings in DENTSPLY SIRONA by 1,753.5% during the fourth quarter. KBC Group NV now owns 269,763 shares of the medical instruments supplier's stock valued at $9,601,000 after buying an additional 255,209 shares during the period. Royal London Asset Management Ltd. raised its stake in DENTSPLY SIRONA by 8.3% in the fourth quarter. Royal London Asset Management Ltd. now owns 96,106 shares of the medical instruments supplier's stock worth $3,420,000 after buying an additional 7,381 shares in the last quarter. Finally, Cibc World Markets Corp purchased a new stake in DENTSPLY SIRONA during the fourth quarter worth $761,000. 95.70% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several research analysts have recently commented on XRAY shares. Barrington Research reissued an "outperform" rating and issued a $36.00 price target on shares of DENTSPLY SIRONA in a research report on Friday, September 20th. Robert W. Baird lowered their price target on shares of DENTSPLY SIRONA from $33.00 to $31.00 and set a "neutral" rating on the stock in a report on Monday, July 22nd. Needham & Company LLC reiterated a "buy" rating and set a $34.00 price objective on shares of DENTSPLY SIRONA in a research note on Tuesday, August 20th. Evercore ISI lowered their target price on shares of DENTSPLY SIRONA from $28.00 to $27.00 and set an "outperform" rating for the company in a research note on Tuesday, July 9th. Finally, Stifel Nicolaus reduced their price target on DENTSPLY SIRONA from $30.00 to $28.00 and set a "hold" rating on the stock in a research report on Thursday, July 18th. Five research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat, DENTSPLY SIRONA presently has a consensus rating of "Moderate Buy" and an average target price of $33.22.

DENTSPLY SIRONA Stock Performance

DENTSPLY SIRONA stock traded down $0.29 during trading hours on Thursday, hitting $24.71. 1,896,434 shares of the stock traded hands, compared to its average volume of 3,037,823. The firm's 50 day moving average price is $25.53 and its 200-day moving average price is $27.45. The company has a debt-to-equity ratio of 0.57, a current ratio of 1.33 and a quick ratio of 0.87. The stock has a market capitalization of $5.13 billion, a price-to-earnings ratio of -56.82, a P/E/G ratio of 1.30 and a beta of 1.00. DENTSPLY SIRONA Inc. has a 1 year low of $23.58 and a 1 year high of $37.60.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last announced its quarterly earnings data on Wednesday, July 31st. The medical instruments supplier reported $0.49 EPS for the quarter, missing the consensus estimate of $0.50 by ($0.01). The business had revenue of $984.00 million for the quarter, compared to analyst estimates of $993.61 million. DENTSPLY SIRONA had a negative net margin of 4.75% and a positive return on equity of 11.86%. The business's revenue was down 4.3% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.51 earnings per share. As a group, equities analysts expect that DENTSPLY SIRONA Inc. will post 1.99 EPS for the current fiscal year.

DENTSPLY SIRONA Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, October 11th. Stockholders of record on Friday, September 27th will be paid a $0.16 dividend. The ex-dividend date is Friday, September 27th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 2.59%. DENTSPLY SIRONA's payout ratio is -145.45%.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.